Network-Informed Gene Ranking Tackles Genetic Heterogeneity in Exome-Sequencing Studies of Monogenic Disease.
1135 - 1144
MetadataShow full item record
Genetic heterogeneity presents a significant challenge for the identification of monogenic disease genes. Whole-exome sequencing generates a large number of candidate disease-causing variants and typical analyses rely on deleterious variants being observed in the same gene across several unrelated affected individuals. This is less likely to occur for genetically heterogeneous diseases, making more advanced analysis methods necessary. To address this need, we present HetRank, a flexible gene-ranking method that incorporates interaction network data. We first show that different genes underlying the same monogenic disease are frequently connected in protein interaction networks. This motivates the central premise of HetRank: those genes carrying potentially pathogenic variants and whose network neighbors do so in other affected individuals are strong candidates for follow-up study. By simulating 1,000 exome sequencing studies (20,000 exomes in total), we model varying degrees of genetic heterogeneity and show that HetRank consistently prioritizes more disease-causing genes than existing analysis methods. We also demonstrate a proof-of-principle application of the method to prioritize genes causing Adams-Oliver syndrome, a genetically heterogeneous rare disease. An implementation of HetRank in R is available via the Website http://sourceforge.net/p/hetrank/.
AuthorsDand, N; Schulz, R; Weale, ME; Southgate, L; Oakey, RJ; Simpson, MA; Schlitt, T
- College Publications 
Showing items related by title, author, creator and subject.
WS57: Medical Genetics: Development of Ethical Dimensions in Clinical Practice and Research (14-Oct-2014) History of Twentieth Century Medicine Group; History of Modern Biomedicine Research Group; Farnetti T (2017-06-06)Selection of photos taken at the Witness Seminar “Medical Genetics: Development of Ethical Dimensions in Clinical Practice and Research" held by the History of Modern Biomedicine Research Group, 14-Oct-2014. Participants: ...
History of Twentieth Century Medicine Group; History of Modern Biomedicine Research Group (2017-05-31)Selection of photos taken at the Witness Seminar “Clinical Genetics in Britain: Origins and development” held by the History of Twentieth Century Medicine Group, 23-Sep-2008. Participants: Ms Chris Barnes, Dr Caroline ...
Disanto, G; Sandve, GK; Berlanga-Taylor, AJ; Morahan, JM; Dobson, R; Giovannoni, G; Ramagopalan, SV (2012)More than 50 genomic regions have now been shown to influence the risk of multiple sclerosis (MS). However, the mechanisms of action, and the cell types in which these associated variants act at the molecular level remain ...